Women account for 50.8% of the U.S. population, yet they only represent 14.8% of all CEOs in the U.S., according to the Center for American Progress. About 78.4% of healthcare industry workers – but only 34.3% of all surgeons and physicians and 15.9% of medical school deans – are women, the center reports. And according to […]
Medtronic (NYSE:MDT) this week said it took out a stake with an exclusive option to buy in Arsenal Medical subsidiary Arsenal AAA. Arsenal AAA is developing a hemostatic foam and delivery system designed to reduce the chance of endoleaks after the placement of a stent graft to treat an abdominal aortic aneurysm. Arsenal president & CEO Maria Palasis told MassDevice.com that the product is designed […]
Sister companies Arsenal Medical and 480 Biomedical said yesterday that they raised $26.5 million in joint funding to advance their respective product platforms. Arsenal raised $16 million and 480 Biomedical $10.5 million from Polaris Partners, North Bridge Venture Partners and Intersouth Partners, the companies said; 480 Biomedical’s round also included a long-term strategic investor. Conversions […]
On July 15, 2014, MassDevice.com brought together 4 senior medtech leaders to discuss the future of the medical device industry at our DeviceTalks Boston event.
Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.
The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic’s center for cardiovascular diagnostics and prevention.
Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.
Partners Healthcare’s Center won a research grant to pilot a text messaging program aimed at helping diabetic patients manage their condition.
The grant, provided by McKesson, was awarded to the hospital system’s Center for Connected Health.
The program, called Mobilizing for Health, targets under-served patients to study whether personalized text messages have an impact on clinical outcomes and physical activity in people with Type II diabetes, who are often obese and have low activity levels.